SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,611.37 -43.23
( -0.06%)

Global Indices

Nasdaq

51,626.09 -1,142.23
(-2.16%)

Dow Jones

7,338.46 -111.32
(-1.49%)

Hang Seng

61,899.63 465.44
(0.76%)

Nikkei 225

10,896.96 25.94
(0.24%)

Forex

USD-INR

95.71 -0.26
(-0.27%)

EUR-INR

108.89 -0.40
(-0.37%)

GBP-INR

127.22 -0.62
(-0.49%)

JPY-INR

0.58 0.00
(-0.38%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

34.29

847.27

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.07

Back

Kati patang Lifestyle reports consolidated net loss of Rs 2.82 crore in the December 2025 quarter

Feb 06,2026

Net Loss of Kati patang Lifestyle reported to Rs 2.82 crore in the quarter ended December 2025 as against net loss of Rs 1.13 crore during the previous quarter ended December 2024. Sales declined 40.09% to Rs 2.60 crore in the quarter ended December 2025 as against Rs 4.34 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2.60	4.34	-40
OPM %	-106.92	-30.88	-
PBDT	-2.73	-1.48	-84
PBT	-2.76	-1.54	-79
NP	-2.82	-1.13	-150

77,611.37 -43.23 ( -0.06%)

51,626.09 -1,142.23 (-2.16%)

7,338.46 -111.32 (-1.49%)

61,899.63 465.44 (0.76%)

10,896.96 25.94 (0.24%)

95.71 -0.26 (-0.27%)

108.89 -0.40 (-0.37%)

127.22 -0.62 (-0.49%)

0.58 0.00 (-0.38%)